Tuberculin reactivity in bacille Calmette-Guérin vaccinated populations: A compilation of international data

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 8, 2006, Pages 883-891

  Joos, Timothy J ^a,d   Miller, W C ^b   Murdoch, D M ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

BCG vaccine; PPD; Review; Tuberculin test

Indexed keywords

VACCINE;

ADULT; ARTICLE; BCG VACCINATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

AGE FACTORS; BCG VACCINE; EMIGRATION AND IMMIGRATION; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33746865570     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Wolleswinkel-van B J, Nagelkerke N J, Broekmans J F, Borgdorff M W. The impact of immigration on the elimination of tuberculosis in the Netherlands: a model based approach. Int J Tuberc Lung Dis 2002; 6: 130-136.
2. Ellis E, Phypers M, Sheardown C, Allegakone M, Sauvé L. Tuberculosis in Canada 2002. Ottawa, Canada: Public Health Agency of Canada, 2004. http://www.phac-aspc.gc.ca/publicat/tbcan02/pdf/tbcan_2002_e.pdf Accessed January 2006.
3. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2004. MMWR 2005; 54: 245-249.
4. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631-635.
5. Nguyen M, Perry S, Parsonnet J. QuantiFERON-TB predicts tuberculin skin test boosting in US foreign-born. Int J Tuberc Lung Dis 2005; 9: 985-991.
6. Ashley M, Siebenmann C. Tuberculin skin sensitivity following BCG vaccination with vaccines of high and low viable counts. Can Med Assoc J 1967; 97: 1335-1338.
7. Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull World Health Organ 1972; 47: 49-58.
8. Landi S, Ashley M, Grzybowski S. Tuberculin sensitivity following the intradermal and multiple puncture methods of BCG vaccination. Can Med Assoc J 1967; 97: 222-225.
9. Ildirim I, Hacimustafaoglu M, Ediz B. Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr Infect Dis J 1995; 14: 1060-1063.
10. Sepulveda R, Ferrer X, Latrach C, Sorensen R. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990; 142: 24-28.
11. Joncas J, Robitaille R, Gauthier T. Interpretation of the PPD skin test in BCG-vaccinated children. Can Med Assoc J 1975; 113: 127-128.
12. Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965; 36: 624-627.
13. Margus J, Khassis Y. The tuberculin sensitivity in BCG vaccinated infants and children in Israel. Acta Tuberc Pneumonol Scand 1965; 46: 113-122.
14. Sinha D, Bang F. Protein and calorie malnutrition, cell-mediated immunity, and BCG vaccination in children from rural West Bengal. Lancet 1976; 2: 531-534.
15. Friedland I. The booster effect with repeat tuberculin testing in children and its relationship to BCG vaccination. S Afr Med J 1990; 77: 387-389.
16. Guld J, Bentzon M, Bleiker M, Griep W, Magnusson M, Waaler H. Standaridization of a new batch of purified tuberculin (PPD) intended for international use. Bull World Health Organ 1958; 19: 845-951.
17. Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
18. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2005.349. Geneva, Switzerland: WHO, 2005. http://www.who.int/tb/publications/global_report/2005 Accessed January 2006.
19. Al-Kassimi F, Abdullah A, Al-Hajjaj M, Al-Orainey I, Bamgboye E, Chowdhury M. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tubercle Lung Dis 1993; 74: 254-260.
20. Al-Kassimi F, Abdullah A, Al-Orainey I, et al. The significance of positive Mantoux reactions in BCG-vaccinated children. Tubercle 1991; 72: 101-104.
21. Almeida L, Barbieri M, Carvalho da Paixao A, Cuevas L. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001; 20: 1061-1065.
22. Amrane R. Results of a national tuberculosis survey carried out from 1980 to 1989 in Algeria. Tubercle Lung Dis 1996; 77: 59-66.
23. Arantes G, Costa Nardy S, Nassar J. The trend in the risk of tuberculous infection in an area with wide coverage with BCG vaccination. Rev Saude Publ 1985; 19: 95-107.
24. Azbite M. Tuberculin survey in Ethiopia. Kekkaku 1992; 67: 539-544.
25. Ballew K, Becker D. Tuberculosis screening in adults who have received Bacille Calmette-Guerin vaccine. Southern Med J 1995; 88: 1025-1030.
26. Barr R, Menzies R. The effect of war on tuberculosis. Tubercle Lung Dis 1994; 75: 251-259.
27. Bener A, Uduman S, Bin-Othman S. Factors associated with tuberculin reactivity among children in United Arab Emirates. Respir Med 1996; 90: 89-94.
28. Bierrenbach A, Cunha S, Barreto M, et al. Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage. Pan Am J Public Health 2003; 13: 285-293.
29. Bosman M, Swai O, Kwamanga D, Agwanda R, Idukitta G, Misljenovic O. National tuberculin survey of Kenya, 1986-1990. Int J Tuberc Lung Dis 1998; 2: 272-280.
30. Bozaykut A, Atay E, Sevim H, Atay Z, Ceran O. Effect of BCG vaccine on tuberculin skin tests in 7-11-year-old children. Acta Paediatrica 2004; 93: 1033-1035.
31. Bozaykut A, Ipek I O, Ozkars M Y, Seren L P, Atay E, Atay Z. Effect of BCG vaccine on tuberculin skin tests in 1-6-year-old children. Acta Paediatrica 2002; 99: 235-238.
32. Casa Garcia I, Ruiz Manzano J, Carreras Molas A, Segura Egea A, Esteve Pardo M, Casas Gracia X. Prevalence of tuberculosis in a population from Kosovo sheltered in Catalonia, Spain. Medicina Clinica 2001; 116: 770-771.
33. Cauthen G, Snider D, Onorato I. Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med 1994; 149: 1597-1600.
34. Centers for Disease Control and Prevention. Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage-Botswana, 1996. MMWR 1997; 46: 846-851.
35. Ciesielski S. BCG vaccination and the PPD test: what the clinician needs to know. J Fam Pract 1995; 40: 76-80.
36. Ciesielski S, Seed J, Esposito D, Hunter N. The epidemiology of tuberculosis among North Carolina migrant farm workers. JAMA 1991; 265: 1715-1719.
37. El-Kassimi F, Abdullah A, Al-Orainey I, Lambourne A, Bener A, Al-Hajjaj M. Tuberculin survey in the eastern province of Saudi Arabia. Respir Med 1991; 85: 111-116.
38. Getchell W, Davis C, Gilman J, Urueta G, Ruiz-Huidobro E, Gilman R. Basic epidemiology of tuberculosis in Peru: a prevalence study of tuberculin sensitivity in a pueblo joven. Am J Trop Med Hyg 1992; 47: 721-729.
39. Gloyd S, Lopez J, Mercado F, Durning J. Risk of infection by Mycobacterium tuberculosis in Jalisco, Mexico. Bol Of Sanit Panam 1991; 111: 393-401.
40. Guitekin A, Akbas L, Gokalp A, Oguz A, Ozgur S. PPD screening in school children with and without BCG vaccination. Mikrobiyoloji Bult 1987; 21: 257-261.
41. Herranz Alvarez M, Vazquez Gallardo R, Minguella Garcia I, Choucino Garrido N, Otero Baamonde M, Quiles Sotillo P. Retrospective study of tuberculin tests in children under 19. An Esp Pediatr 1996; 44: 234-238.
42. Hizel K, Maral I, Karakus R, Aktas F. The influence of BCG immunization on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis. Clin Microbiol Infect 2004; 10: 980-983.
43. Jaramillo A, Dios R, Elias de Quilcate A. Tuberculin response in schoolchildren in Pacasmayo, Peru. Bol Of Sanit Panam 1989; 107: 388-395.
44. Laniado-Laborin R, Cabrales-Vargas N, Lopez-Espinoza G, Lepe-Zuniga J, Quinonez-Moreno S, Rico-Vargas C. Prevalence of tuberculosis infection in schoolchildren from Tijuana, Mexico. Salud Publica Mex 1998; 40: 47-52.
45. Levitin Y, Baum G, Wartski S. Mantoux testing of 7th graders in Tel Aviv, Israel. Public Health Rev 2001; 29: 63-69.
46. Liard R, Tazir M, Boulahbal F, Perdrizet S. Use of two methods of analysis to estimate the annual rate of tuberculosis infection in southern Algeria. Tubercle Lung Dis 1996; 77: 207-214.
47. Marks G, Bai J, Simpson S, Sullivan E, Stewart G. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med 2000; 162: 1851-1854.
48. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992; 146: 752-756.
49. Menzies R, Vissandjee B, Rocher I, St. Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994; 120: 190-198.
50. Miret-Caudras P, Pina-Guitierrez J. The tuberculin skin test in BCG-vaccinated individuals. Arch Bronconeumol 1998; 34: 421-424.
51. Munoz P, Calzada M, Castanedo J, et al. [Characteristics of tuberculin reactions in Cantabria]. Rev Sanid Hig Publica (Madr) 1990; 64: 91-101.
52. Musoke Mudido P, Guwatudde D, Nakakeeto M, et al. The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis 1999; 3: 891-895.
53. Osman A, Hakim J, Luneborg-Nielsen M, et al. Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia. Tubercle Lung Dis 1994; 75: 38-43.
54. Perez-Stable E, Slutkin G, Paz E, Hopewell P. Tuberculin reactivity in United States and foreign-born Latinos: results of a community-based screening program. Am J Public Health 1986; 76: 643-646.
55. Rangel-Frausto M, Ponce-de-Rosales S, Martinez-Albaroa C, Haslov K. Tuberculosis and tuberculin quality: best intentions, misleading results. Infect Control Hosp Epidemiol 2001; 22: 481-484.
56. Rollan Rollan A, Bonilla Miera C, Gonzalez de Aledo Linos A, Diego Santamaria M, Obeso Garcia M, Montes Conde A. Tuberculosis infection prevalence in children younger than 7 years of age in Cantabria. What is the recommended periodicity for the tuberculin test? An Esp Pediatr 1997; 46: 241-244.
57. Saiman L, Aronson J, Zhou J, et al. Prevalence of infectious diseases among internationally adopted children. Pediatrics 2001; 108: 608-612.
58. Saito M, Bautista C, Gilman R, Bowering A, Levy M, Evans C. The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shanty town, Peru. Int J Tuberc Lung Dis 2004; 8: 842-847.
59. Salaniponi F, Kwnajana J, Veen J, Misljenovic O, Borgdorff M. Risk of infection with Mycobacterium tuberculosis in Malawi: national tuberculin survey 1994. Int J Tuberc Lung Dis 2004; 8: 718-723.
60. Spinaci S, De Virgilio G, Bugiani M, Linari D, Bertolaso G. Tuberculin survey among Afghan refugee children. Tuberculosis control programme among Afghan refugees in North West Frontier Province (NWFP) Pakistan. Tubercle 1989; 70: 83-92.
61. Uduman S, Bener A, Bin Othman S. Neonatal BCG vaccination and tuberculin skin sensitivity among schoolchildren of the United Arab Emirates. Ann Trop Paediatr 1996; 16: 353-357.
62. Weinstock D, Hahn O, Wittkamp M, Sepkowitz K, Khechinashvili G, Blumberg H. Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia. Int J Tuberc Lung Dis 2001; 5: 164-169.
63. Willame J, Prignot J, Nsinga M, Mulumba K. Transversal tuberculin and X-ray survey of the tuberculosis endemic in Kinshasa, Zaire (1978-79). Ann Soc Belge Med Trop 1981; 61: 489-501.
64. Young T, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tubercle Lung Dis 1992; 73: 94-100.
65. Menzies R, Vissandjee B. Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-625.
66. Trébucq A, Guérin N, Ali Ismael H, Bernatas J J, Sèvre J P, Rieder H L. Prevalence and trends of infection with Mycobacterium tuberculosis in Djibouti, testing an alternative method. Int J Tuberc Lung Dis 2005; 9: 1097-1104.
67. Wang L, Turner M, Elwood R, Schulzer M, FitzGerald J. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
68. American Academy of Pediatrics, Committee on Infectious Diseases. Update on tuberculosis skin testing of children. Pediatrics 1996; 97: 282-284.
69. Miller F, Seal R, Taylor M. Tuberculosis in children. Boston, MA, USA: Little Brown, 1963.
70. Lobato M, Cummings K, Will D, Royce S. Tuberculosis in children and adolescents: California, 1985 to 1995. Paediatr Infect Dis J 1998; 17: 407-411.